Structural insights into HRI kinase activity and inhibition
1MRC Protein Phosphorylation and Ubiquitination Unit, Faculty of Life Sciences, University of Dundee, Dundee, U.K.
None:
Haem-regulated inhibitor (HRI) is emerging as a potential therapeutic target in several disease areas, including cancers such as multiple myeloma and neurodegenerative disease. As one of four related mammalian kinases that phosphorylate the mRNA translation machinery substrate eIF2α, it has a central role in sensing several disparate proteotoxic stresses and preventing subsequent rounds of protein production. In this review, we will examine the latest research on the structural and molecular basis of HRI inhibition and activation, examining both regulatory biological interactions with proteins and cofactors. What emerges is that despite almost 75 years since the first identification of HRI, we still know remarkably little about how this kinase functions and is regulated.
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
Enzyme Inhibition
Regulation of the Unfolded Protein Response
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Protein-protein Interfaces


